Literature DB >> 15743797

The role of protease-activated receptor-1 in bone healing.

Shu Jun Song1, Charles N Pagel, Therese M Campbell, Robert N Pike, Eleanor J Mackie.   

Abstract

Protease-activated receptor (PAR)-1, a G-protein-coupled receptor activated by thrombin, mediates thrombin-induced proliferation of osteoblasts. The current study was undertaken to define the role of PAR-1 in bone repair. Holes were drilled transversely through the diaphysis of both tibiae of PAR-1-null and wild-type mice. Three days later, fewer cells had invaded the drill site from adjacent bone marrow in PAR-1-null mice than in wild-type mice, and a lower percentage of cells were labeled with [(3)H]thymidine in PAR-1-null drill sites. More osteoclasts were also observed in the drill site of PAR-1-null mice than in wild-type mice 7 days after drilling. New mineralized bone area was less in the drill site and on the adjacent periosteal surface in PAR-1-null mice than in wild-type mice at day 9. From day 14, no obvious differences could be seen between PAR-1-null and wild-type tibiae. In vitro thrombin caused a dose-dependent increase in proliferation of bone marrow stromal cells isolated from wild-type mice but not PAR-1-null mice. Thrombin stimulated survival of bone marrow stromal cells from both wild-type and PAR-1-null mice, but it did not affect bone marrow stromal cell migration in either wild-type or PAR-1-null cells. The results indicate that PAR-1 plays an early role in bone repair.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743797      PMCID: PMC1602347          DOI: 10.1016/S0002-9440(10)62306-1

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  43 in total

Review 1.  Protease-activated receptors: sentries for inflammation?

Authors:  T M Cocks; J D Moffatt
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

Review 2.  Thrombin as a regulator of inflammation and reparative processes in tissues.

Authors:  S M Strukova
Journal:  Biochemistry (Mosc)       Date:  2001-01       Impact factor: 2.487

3.  Increased marrow-derived osteoprogenitor cells and endosteal bone formation in mice lacking thrombospondin 2.

Authors:  K D Hankenson; S D Bain; T R Kyriakides; E A Smith; S A Goldstein; P Bornstein
Journal:  J Bone Miner Res       Date:  2000-05       Impact factor: 6.741

4.  Dissecting the hematopoietic microenvironment. IX. Further characterization of murine bone marrow stromal cells.

Authors:  P E Penn; D Z Jiang; R G Fei; E Sitnicka; N S Wolf
Journal:  Blood       Date:  1993-03-01       Impact factor: 22.113

5.  A metaphyseal defect model of the femur for studies of murine bone healing.

Authors:  H Uusitalo; J Rantakokko; M Ahonen; T Jämsä; J Tuukkanen; V KäHäri; E Vuorio; H T Aro
Journal:  Bone       Date:  2001-04       Impact factor: 4.398

6.  A standardized experimental fracture in the mouse tibia.

Authors:  A Hiltunen; E Vuorio; H T Aro
Journal:  J Orthop Res       Date:  1993-03       Impact factor: 3.494

7.  Thrombin stimulates fibroblast chemotaxis and replication.

Authors:  K E Dawes; A J Gray; G J Laurent
Journal:  Eur J Cell Biol       Date:  1993-06       Impact factor: 4.492

8.  Thrombin receptor activating peptide (TRAP) stimulates mitogenesis, c-fos and PDGF-A gene expression in human vascular smooth muscle cells.

Authors:  C Kanthou; O Benzakour; G Patel; J Deadman; V V Kakkar; F Lupu
Journal:  Thromb Haemost       Date:  1995-11       Impact factor: 5.249

9.  Pertussis toxin-sensitive activation of p21ras by G protein-coupled receptor agonists in fibroblasts.

Authors:  E J van Corven; P L Hordijk; R H Medema; J L Bos; W H Moolenaar
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

10.  Activation of Src family kinase activity by the G protein-coupled thrombin receptor in growth-responsive fibroblasts.

Authors:  Y H Chen; J Pouysségur; S A Courtneidge; E Van Obberghen-Schilling
Journal:  J Biol Chem       Date:  1994-11-04       Impact factor: 5.157

View more
  15 in total

1.  Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.

Authors:  Xiaotun Zhang; Wenbin Wang; Lawrence D True; Robert L Vessella; Thomas K Takayama
Journal:  Prostate       Date:  2009-05-15       Impact factor: 4.104

2.  Bone healing after dental extractions in irradiated patients: a pilot study on a novel technique for volume assessment of healing tooth sockets.

Authors:  Jimoh Olubanwo Agbaje; Reinhilde Jacobs; Katleen Michiels; Mahmoud Abu-Ta'a; Daniel van Steenberghe
Journal:  Clin Oral Investig       Date:  2008-11-05       Impact factor: 3.573

Review 3.  Regulation of long-term repopulating hematopoietic stem cells by EPCR/PAR1 signaling.

Authors:  Shiri Gur-Cohen; Orit Kollet; Claudine Graf; Charles T Esmon; Wolfram Ruf; Tsvee Lapidot
Journal:  Ann N Y Acad Sci       Date:  2016-03-01       Impact factor: 5.691

4.  Protease-Activated Receptor 1 Deletion Causes Enhanced Osteoclastogenesis in Response to Inflammatory Signals through a Notch2-Dependent Mechanism.

Authors:  Sandra Jastrzebski; Judith Kalinowski; Sehwan Mun; Bongjin Shin; Naga Suresh Adapala; Christian E Jacome-Galarza; Faryal Mirza; H Leonardo Aguila; Hicham Drissi; Archana Sanjay; Ernesto Canalis; Sun-Kyeong Lee; Joseph A Lorenzo
Journal:  J Immunol       Date:  2019-05-20       Impact factor: 5.422

5.  Protease-activated receptor-1 inhibits proliferation but enhances leukemia stem cell activity in acute myeloid leukemia.

Authors:  S Goyama; M Shrestha; J Schibler; L Rosenfeldt; W Miller; E O'Brien; B Mizukawa; T Kitamura; J S Palumbo; J C Mulloy
Journal:  Oncogene       Date:  2016-11-07       Impact factor: 9.867

6.  A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure.

Authors:  Anna Aronovich; Yaniv Nur; Elias Shezen; Chava Rosen; Yael Zlotnikov Klionsky; Irit Milman; Liran Yarimi; David Hagin; Gidi Rechavi; Uriel Martinowitz; Takashi Nagasawa; Paul S Frenette; Dalit Tchorsh-Yutsis; Yair Reisner
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

7.  Neuroprotective activities of activated protein C mutant with reduced anticoagulant activity.

Authors:  Huang Guo; Itender Singh; Yaoming Wang; Rashid Deane; Theresa Barrett; José A Fernández; Nienwen Chow; John H Griffin; Berislav V Zlokovic
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

8.  Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.

Authors:  Mateusz Kolanczyk; Jirko Kühnisch; Nadine Kossler; Monika Osswald; Sabine Stumpp; Boris Thurisch; Uwe Kornak; Stefan Mundlos
Journal:  BMC Med       Date:  2008-07-31       Impact factor: 8.775

Review 9.  The characteristics of thrombin in osteoarthritic pathogenesis and treatment.

Authors:  Pei-Yu Chou; Chen-Ming Su; Chun-Yin Huang; Chih-Hsin Tang
Journal:  Biomed Res Int       Date:  2014-09-16       Impact factor: 3.411

10.  Comparative evaluation of the biological properties of fibrin for bone regeneration.

Authors:  Joung-Hwan Oh; Hye-Jin Kim; Tae-Il Kim; Kyung Mi Woo
Journal:  BMB Rep       Date:  2014-02       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.